Collectively, our findings demonstrate that combining metformin with L-asparaginase enhances their pro-apoptotic efficacy in both OxPhos and glycolytic DLBCL by cooperatively targeting multiple metabolic pathways (Figure 2G and Figure 3D). This evidence concerns the gene ASPG and diffuse large B-cell lymphoma.